Iradimed Share Price Today
(NASDAQ: IRMD)

Name: Iradimed Share Price Today (NASDAQ: IRMD) - Iradimed Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Iradimed share price is $59.93 & ₹5,176.00 as on 28 Jan 2025, 2.30 'hrs' IST

$59.93

▲

-0.55

(-0.91%)

Market is closed - opens 8 PM, 28 Jan 2025

View live Iradimed share price in Dollar and Rupees. Guide to invest in Iradimed stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iradimed, along with analyst recommendations, forecasts, and comprehensive financials.

Iradimed share price movements

Today's Low: $59.77
Today's High: $60.79
$59.93
0.27%
Downside
Day's Volatility :1.68%
Upside
1.41%
52 Weeks Low: $40.18
52 Weeks High: $61.00
$59.93
32.96%
Downside
52 Weeks Volatility :34.13%
Upside
1.75%

Iradimed (IRMD) Returns

Period	Iradimed Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	15.09%	-2.9%	0.0%
6 Months	30.29%	-3.8%	0.0%
1 Year	39.68%	3.6%	0.0%
3 Years	51.88%	12.9%	-8.4%

Iradimed (IRMD) Key Statistics

in dollars & INR

Previous Close	$60.48
Open	$60.04
Today's High	$60.79
Today's Low	$59.77
Market Capitalization	$764.6M
Today's Volume	$23.6K
52 Week High	$60.9999
52 Week Low	$40.18
Revenue TTM	$71.3M
EBITDA	$22.2M
Earnings Per Share (EPS)	$1.49
PE Ratio	40.49
Dividend Yield	1.01%
Profit Margin	26.12%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	23.58%

How to invest in Iradimed Stock (IRMD) from India?

It is very easy for Indian residents to invest directly in Iradimed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iradimed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iradimed or IRMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iradimed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iradimed shares which would translate to 0.014 fractional shares of Iradimed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iradimed, in just a few clicks!

Returns in Iradimed (IRMD) for Indian investors in Rupees

The Iradimed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Iradimed investment value today

Current value as on today

₹1,42,320

Returns

₹42,320

(+42.32%)

Returns from Iradimed Stock

₹38,406 (+38.41%)

Dollar Returns

₹3,913 (+3.91%)

Indian investors sentiment towards Iradimed (IRMD)

14%

Period: Dec 28, 2024 to Jan 27, 2025. Change in 30 Days versus previous period

Search volume for Iradimed on INDmoney from India has grown in the last 30 days as on Jan 28, 2025. 14% more investors are searching Iradimed in the last 30 days versus the previous period.

Global Institutional Holdings in Iradimed

BlackRock Inc
7.42%
Nine Ten Capital Management LLC
7.15%
Renaissance Technologies Corp
4.26%
Vanguard Group Inc
4.06%
Copeland Capital Management, LLC
3.33%
Ranger Investment Management LP
1.97%

Analyst Recommendation on Iradimed

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Iradimed(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iradimed Stock (IRMD)

What analysts predicted

Upside of 8.46%

Target:

$65.00

Current:

$59.93

Insights on Iradimed Stock (Ticker Symbol: IRMD)

Price Movement
In the last 1 month, IRMD stock has moved up by 10.6%
Increasing Revenue
Revenue is up for the last 18 quarters, 6.79M → 18.32M (in $), with an average increase of 5.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 4.13M → 5.04M (in $), with an average increase of 9.3% per quarter
IRMD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 66.8% return, outperforming this stock by 26.5%
IRMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.8% return, outperforming this stock by 67.8%
Price to Sales
ForIRMD every $1 of sales, investors are willing to pay $10.7, whereas for Boston Scientific Corp., the investors are paying $9.4 for every $1 of sales.

IRMD Iradimed Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.4M	↑ 31.88%
Net Income	$6.3M	↑ 1161.29%
Net Profit Margin	20.71%	↑ 18.54%

	FY19	Y/Y Change
Revenue	$38.5M	↑ 26.54%
Net Income	$9.6M	↑ 52.79%
Net Profit Margin	25.0%	↑ 4.29%

	FY20	Y/Y Change
Revenue	$31.7M	↓ 17.65%
Net Income	$1.4M	↓ 85.79%
Net Profit Margin	4.32%	↓ 20.68%

	FY21	Y/Y Change
Revenue	$41.8M	↑ 31.83%
Net Income	$9.3M	↑ 581.19%
Net Profit Margin	22.3%	↑ 17.98%

	FY22	Y/Y Change
Revenue	$53.3M	↑ 27.48%
Net Income	$12.8M	↑ 37.55%
Net Profit Margin	24.06%	↑ 1.76%

	FY23	Y/Y Change
Revenue	$65.6M	↑ 23.0%
Net Income	$17.2M	↑ 34.03%
Net Profit Margin	26.22%	↑ 2.16%

	Q2 FY23	Q/Q Change
Revenue	$16.1M	↑ 4.23%
Net Income	$4.2M	↑ 22.72%
Net Profit Margin	25.91%	↑ 3.9%

	Q3 FY23	Q/Q Change
Revenue	$16.5M	↑ 2.32%
Net Income	$5.1M	↑ 21.23%
Net Profit Margin	30.7%	↑ 4.79%

	Q4 FY23	Q/Q Change
Revenue	$17.5M	↑ 5.74%
Net Income	$4.5M	↓ 10.41%
Net Profit Margin	26.01%	↓ 4.69%

	Q1 FY24	Q/Q Change
Revenue	$17.6M	↑ 0.84%
Net Income	$4.1M	↓ 8.88%
Net Profit Margin	23.51%	↓ 2.5%

	Q2 FY24	Q/Q Change
Revenue	$17.9M	↑ 1.88%
Net Income	$4.9M	↑ 18.49%
Net Profit Margin	27.34%	↑ 3.83%

	Q3 FY24	Q/Q Change
Revenue	$18.3M	↑ 2.21%
Net Income	$5.0M	↑ 3.03%
Net Profit Margin	27.55%	↑ 0.21%

	FY18	Y/Y Change
Profit	$23.2M	↑ 32.64%

	FY19	Y/Y Change
Profit	$29.7M	↑ 27.87%

	FY20	Y/Y Change
Profit	$23.6M	↓ 20.63%

	FY21	Y/Y Change
Profit	$32.0M	↑ 35.95%

	FY22	Y/Y Change
Profit	$41.3M	↑ 28.81%

	FY23	Y/Y Change
Profit	$50.2M	↑ 21.5%

	Q2 FY23	Q/Q Change
Profit	$12.2M	↑ 3.97%

	Q3 FY23	Q/Q Change
Profit	$12.8M	↑ 5.34%

	Q4 FY23	Q/Q Change
Profit	$13.4M	↑ 4.48%

	Q1 FY24	Q/Q Change
Profit	$13.4M	↓ 0.19%

	Q2 FY24	Q/Q Change
Profit	$14.0M	↑ 4.65%

	Q3 FY24	Q/Q Change
Profit	$14.2M	↑ 1.3%

	FY18	Y/Y Change
Operating Cash Flow	$7.4M	↑ 115.93%
Investing Cash Flow	$1.5M	↓ 248.1%
Financing Cash Flow	$929.9K	↓ 148.93%

	FY19	Y/Y Change
Operating Cash Flow	$10.2M	↑ 38.73%
Investing Cash Flow	$3.2M	↑ 111.18%
Financing Cash Flow	$2.0M	↑ 117.25%

	FY20	Y/Y Change
Operating Cash Flow	$5.8M	↓ 43.15%
Investing Cash Flow	$247.0K	↓ 92.29%
Financing Cash Flow	$522.5K	↓ 74.14%

	FY21	Y/Y Change
Operating Cash Flow	$11.3M	↑ 93.52%
Investing Cash Flow	$648.2K	↑ 162.48%
Financing Cash Flow	$24.4K	↓ 95.33%

	FY22	Y/Y Change
Operating Cash Flow	$10.0M	↓ 10.8%
Investing Cash Flow	$-1.4M	↓ 312.11%
Financing Cash Flow	$-12.7M	↓ 52122.11%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.5M	↓ 24.37%
Investing Cash Flow	$-378.3K	↓ 94.23%
Financing Cash Flow	$-89.8K	↓ 99.32%

Iradimed Technicals Summary

Sell

Neutral

Buy

Iradimed is currently in a neutral trading position according to technical analysis indicators.

Iradimed (IRMD) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iradimed Corp	9.78%	30.29%	39.68%	51.88%	133.97%
Medtronic Plc	13.29%	11.61%	3.15%	-12.85%	-23.66%
Edwards Lifesciences Corp.	-7.07%	8.41%	-7.48%	-36.82%	-11.54%
Boston Scientific Corp.	13.67%	37.7%	66.27%	137.62%	134.83%
Stryker Corporation	8.85%	19.41%	25.38%	58.96%	84.4%
Abbott Laboratories	10.84%	18.71%	10.21%	-1.91%	40.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iradimed Corp	40.49	40.49	4.46	1.66	0.24	0.15	0.01	6.59
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iradimed Corp	Buy	$764.6M	133.97%	40.49	26.12%
Medtronic Plc	Buy	$113.3B	-23.66%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-11.54%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	134.83%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	84.4%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	40.23%	34.45	13.99%

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Organization	Iradimed
Employees	148
CEO	Mr. Roger E. Susi
Industry	Health Technology

Management People of Iradimed

Name	Title
Mr. Roger E. Susi	Founder, Chairman, CEO & President
Mr. John F. Glenn	CFO & Corporate Secretary
Mr. Randy Waddell	Vice President of Worldwide Sales & Marketing
Mr. Chris Williamson	Executive Vice President of Continuous Improvement & Information Technology
Mr. Matt Garner	Controller
Mr. Lynn Neuhardt	Vice President of Research & Development

Important FAQs about investing in IRMD Stock from India :

What is Iradimed share price today?

Iradimed share price today stands at $59.93, Open: $60.04 ; Previous Close: $60.48 ; High: $60.79 ; Low: $59.77 ; 52 Week High: $61.00 ; 52 Week Low: $40.18. The stock opens at $60.04, after a previous close of $60.48. The stock reached a daily high of $60.79 and a low of $59.77, with a 52-week high of $61.00 and a 52-week low of $40.18.

Can Indians buy Iradimed shares?

Yes, Indians can invest in the Iradimed (IRMD) from India.

With INDmoney, you can buy Iradimed at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iradimed at zero transaction cost.

How can I buy Iradimed shares from India?

It is very easy to buy Iradimed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iradimed be purchased?

Yes, you can buy fractional shares of Iradimed with INDmoney app.

What are the documents required to start investing in Iradimed stocks?

To start investing in Iradimed, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.